Completed OBSERVATIONAL NCT01421732

Laboratory Diagnosis and Prognosis of Severe Dengue

Sponsor: Children's Hospital Number 1, Ho Chi Minh City, Vietnam

Updated 8 times since 2017 Last updated: Sep 29, 2016 Started: Oct 31, 2010 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01421732, this observational or N/A phase trial focuses on Dengue Fever and remains completed. Sponsored by Children's Hospital Number 1, Ho Chi Minh City, Vietnam, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2023 — Jul 2024 [monthly]

Completed
Jan 2021 — Feb 2023 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Number 1, Ho Chi Minh City, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Number 2 Children's Hospital, Ho Chi Minh City
Oxford University Clinical Research Unit, Vietnam
Red Cross Clinic Of District 8
Tien Giang Provincial Hospital, Tien Giang, Viet Nam

Data source: Oxford University Clinical Research Unit, Vietnam

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ho Chi Minh City, Vietnam